Advanced Injection Options
Platelet-Rich Plasma (PRP), Bone Marrow Aspirate Concentrate (BMAC), and Other Selected Biologic Injection Options
When appropriate, these treatments are incorporated into an individualized, non-surgical plan based on the diagnosis, imaging findings, biomechanical assessment, prior treatment, and functional goals. They may be used alongside rehabilitation, osteopathic treatment, and other image-guided procedures as part of a coordinated approach to the affected functional region.
What Advanced Injection Options May Include
Orthobiologics is a general term used to describe biologically derived treatment options that may be considered in selected musculoskeletal conditions. In practical terms, the term refers to a category of treatments rather than a single procedure.
Two commonly discussed examples are platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC). These are distinct treatment options with different characteristics, preparation methods, and potential applications.
Their role is not defined by the label alone, but by how well they align with the underlying diagnosis, the involved tissue, and the overall clinical context. For that reason, decisions regarding orthobiologic treatment begin with diagnostic clarity rather than treatment selection.
When These Options May Be Discussed
The appropriateness of orthobiologic treatment depends on multiple factors, including the specific diagnosis, the structure involved, imaging findings when relevant, duration of symptoms, prior treatment response, activity demands, and overall treatment goals. These discussions may arise when evaluating selected tendon, ligament, muscle, or joint-related conditions involving the shoulder, hip, knee, ankle, foot, elbow, wrist, or other musculoskeletal regions. They may also be considered within a Sports Medicine evaluation or, in selected cases, as part of a broader assessment of back and neck pain. Not every painful structure is an appropriate target for orthobiologic treatment, and not every clinical scenario benefits from its use. The decision depends on whether the diagnosis, anatomy, and treatment objective support considering an advanced injection option.
Why Selectivity Matters
Orthobiologic treatments are not positioned as routine or protocol-driven interventions. Their use depends on whether the underlying diagnosis, tissue involved, and clinical context support a biologic approach.
Many musculoskeletal conditions improve with well-structured nonoperative care, which may include activity modification, targeted exercise, physical therapy, osteopathic treatment, or image-guided procedures. Orthobiologics are considered when these strategies are insufficient or when a specific indication makes them reasonable to discuss.
Patients often seek these treatments directly. In some cases, they may be appropriate. In others, a different approach may better address the underlying problem. The decision is individualized and not automatic.
Platelet-Rich Plasma (PRP) and Bone Marrow Aspirate Concentrate (BMAC)
Platelet-rich plasma (PRP) is derived from a patient’s own blood and processed for use in selected musculoskeletal settings. Bone marrow aspirate concentrate (BMAC) involves processing bone marrow-derived material and may be discussed in a narrower set of circumstances.
Other orthobiologic approaches also exist, but they are discussed less commonly and only in selected circumstances, particularly when the evidence base is more limited or the clinical role is less clearly defined.
Although both PRP and BMAC are often grouped under the orthobiologic umbrella, they are not the same treatment and are not used interchangeably across all conditions. The evidence base is variable and depends heavily on the indication, the tissue involved, chronicity, severity, and treatment goal. For that reason, PRP and BMAC are considered more selectively than public-facing marketing in this area often suggests.
How Evaluation Works at Network Spine
Evaluation comes first.
This includes a detailed history, focused physical examination, assessment of movement and biomechanics, and imaging review when appropriate. Prior treatments, response patterns, and patient goals are also part of the discussion.
Not every patient seeking orthobiologic treatment is advised to pursue it. In many cases, other strategies—such as a structured rehabilitation plan, an Osteopathic Approach, or targeted procedures—may be more appropriate. Recommendations are guided by clinical judgment rather than predetermined pathways.
Potential Treatment Targets
Depending on the diagnosis, imaging findings, prior treatment, and biomechanical assessment, advanced injection options may be directed to a joint, tendon or tendon attachment, ligament, selected fascial or muscle injury, or certain fibrocartilage structures such as the meniscus. In selected cases involving subchondral bone or a bone-marrow lesion, an intraosseous injection may also be considered.
Particularly in chronic conditions, symptoms often reflect dysfunction across several anatomically and functionally related structures rather than a single isolated target. Treatment may therefore address multiple components of a functional region—such as the spine and supporting soft tissues, the hip and sacroiliac region, or the neck and shoulder complex—as part of a coordinated treatment and rehabilitation plan.
These procedures and targets are not interchangeable. The injectate, structures treated, imaging guidance, procedural sequence, and rehabilitation plan are selected according to the specific clinical findings and functional goals.
Beyond the Injection: Recovery and Follow-Up
The injection is a technical event. The recovery plan is a process.
For selected patients, follow-up is used to assess pain, motion, function, loading tolerance, and the response of the treated region over time.
Physical therapy or structured rehabilitation may be used to guide progressive mobility, strengthening, loading, and return to activity. When relevant examination findings are present, osteopathic manipulative treatment may be incorporated to address mechanical restrictions or compensatory patterns in related regions.
Trigger point treatment may be considered when persistent muscular guarding or myofascial pain is limiting movement or rehabilitation. Other modalities, including shockwave therapy or selected laser-based treatments, may be considered in specific clinical circumstances based on the tissue involved and the broader treatment objective.
Recovery planning may also include discussion of activity progression, sleep, nutrition, and other general health factors that can affect rehabilitation and physical performance.
Not every patient requires each of these treatments. They are selected individually and are not added simply because PRP or BMAC was performed.
The purpose of monitored follow-up is to evaluate progress, identify remaining barriers to function, and modify the treatment plan when clinically appropriate. An advanced injection should not be viewed as a substitute for appropriate rehabilitation, reassessment, or attention to other meaningful contributors to the condition being treated.
Limits of Orthobiologic Treatment
Response to orthobiologic treatment depends on multiple factors, including the tissue being treated, the severity of structural change, and how closely the treatment aligns with the primary pain generator.
Pain may arise from overlapping contributors such as mechanical overload, nerve-related pathology, disc or joint disease, instability, or central sensitization. In these settings, a biologic treatment may not fully address all components of symptoms.
For that reason, improvement may be partial, variable, or limited in some cases. Orthobiologic treatment does not replace the need for accurate diagnosis and a comprehensive treatment strategy.
Practical Considerations
Many orthobiologic treatments are not typically covered as standard insurance benefits. When these options are discussed, considerations may include evidence by indication, expected recovery planning, cost, timing, and whether the proposed treatment meaningfully fits the diagnosis.
These conversations are handled individually and in context. Coverage is not assumed, and financial responsibility depends on the specific treatment and insurance situation.
Why This Approach Is Different
Network Spine is a physician-led practice built around diagnosis-first, judgment-driven care.
Orthobiologics are not presented as a universal solution or routine offering. They are considered selectively, alongside a broader range of options that may include rehabilitation, osteopathic treatment, image-guided injections, and other nonoperative strategies. The goal is not to force a patient into a biologic pathway. The goal is to determine what fits the anatomy, mechanics, timeline, and treatment objective with the least unnecessary escalation.
What are orthobiologic treatments?
Orthobiologic treatments refer to certain biologically derived options, such as platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC), that may be considered in selected musculoskeletal conditions when clinically appropriate.
Are PRP and BMAC the same?
No. PRP and BMAC are different in how they are prepared and how they may be used. The choice between them depends on the specific diagnosis, tissue involved, and overall clinical context.
Are these treatments used for all types of pain?
No. Orthobiologic treatments are considered only when symptoms are likely related to tissues that may respond to this approach.
Are orthobiologic treatments first-line care?
In most cases, no. They are typically considered after initial nonoperative strategies have been evaluated.
How is it determined if this is appropriate?
This is based on clinical evaluation, including history, examination, and imaging when indicated.
Do these treatments guarantee improvement?
No. Response varies based on diagnosis, tissue involved, and individual factors.
Considering an Evaluation
Orthobiologics, including PRP and BMAC, are discussed selectively and only after diagnosis, examination, and review of the broader clinical context. If you would like to request an appointment, you may begin with a general evaluation rather than a procedure-specific request.